Observational Study
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Sep 16, 2016; 8(17): 628-634
Published online Sep 16, 2016. doi: 10.4253/wjge.v8.i17.628
Table 2 Characteristics of tumors and follow-up data
Case listGastric regionLocationTumor size (mm)H. pylori status before ESDSpecimen size (mm)HistologyTumor depthPost-ESD treatmentFollow-up (yr)
1AntrumAnterior wall8Positive30Moderately differentiated adenocarcinomaMRabeprazole8
2AntrumGreater curvature13Positive37Well differentiated adenocarcinomaMOmeprazole11
3AntrumLesser curvature25Positive50Well differentiated adenocarcinomaMRabeprazole13
4AntrumGreater curvature15Positive32Well differentiated adenocarcinomaMRabeprazole5
5AntrumLesser curvature8Negative20Well differentiated adenocarcinomaMRabeprazole2
6AntrumGreater curvature10Negative20High-grade dysplasiaMOmeprazole7
7AntrumLesser curvature25Positive40Well differentiated adenocarcinomaMOmeprazole + sucralfate4
8AntrumGreater curvature20Positive40High-grade dysplasiaMEsomeprazole + sucralfate4
9AntrumAnterior wall12Positive22High-grade dysplasiaMOmeprazole + sucralfate4
10AntrumGreater curvature25Negative40Inflammatory lesion indefinite for dysplasiaMEsomeprazole + sucralfate4
11AntrumAnterior wall20Negative35Inflammatory fibroid polypSMOmeprazole + sucralfate2
12AntrumGreater curvature30Positive40High-grade dysplasiaMOmeprazole + sucralfate1
13AngleLesser curvature45Negative82Well differentiated adenocarcinomaMRabeprazole2
14AntrumPosterior wall20Negative32High-grade dysplasiaMOmeprazole + sucralfate1